(S)-2-(tert-Butoxycarbonyl)-2-azaspiro[4.4]nonane-3-carboxylic acid, 97%, 1g

4-(2-Aminoethyl)thiomorpholine, 95.0%, 5g

(S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea, 98.0%, 10mg

1-Butanol, min. 99.5%, for synthesis, 10 l, tinplate

2,3-Dihydro-benzofuran-2-carbonyl chloride, 95.0%, 1g

2-Methylpyrazolo[1,5-a]pyrazin-4(5H)-one, 97%, 100mg

2-(3-Fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 25g

2-Methylcyclohexylamine (cis- and trans- mixture)>95.0%(GC)(T)25mL

[S(R)]-N-[(1R)-1-[2-((tert-Butyldiphenylsilyl)oxy)phenyl)]-2-yl-2-(diphenylphosphino)ethyl]-2-methyl-2-propanesulfinamide, 95%, 50mg

methyl 3-hydroxy-2-naphthoate, 99.0%, 5g

4-(1,7-Naphthyridin-8-ylamino)-4-oxobutanoic acid, 95.0%, 1g

2-Ethylphenylhydrazine hydrochloride, 98.0%, 100g

N-Boc-2-(3'-Chlorophenyl)-L-glycine, 97.0%, 10g